Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease. Im Y, Kim SY, Kim DH, Jhun BW, et al. Chest 2024;165:288-302.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Im Y, Kim SY, Kim DH, Jhun BW, et al. Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease. Chest 2024;165:288-302.
PMID: 37661004